N -myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
ConclusionsThese results support further evaluation of NMT immunohistochemistry for patient selection and clinical trials of NMT inhibition in breast cancer patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Biology | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Epithelial Cancer | Hormones | Oral Cancer